×
Close
Sign Up
Login
Home
Library S
Library D
Events & Partner
WeMed
MDLA Events Platform
Events
Media Partners
Educational Partner
User Tools
FAQ/USER GUIDE
Language
English
中文/ Chinese
French
Português
Español
Arabic
Russian
Contact Us
×
Close
mdla_1
mdla_2
mdla_3
mdla_4
mdla_5
mdla_6
Categories
Hematology
5724
Global Medical University
5219
Allergy
1829
Anatomy & Morphology
1643
Andrology
394
Anesthesia & Intensive Care
1302
Anesthesiology
5625
Audiology & Speech-Language Pathology
355
Behavioral Sciences
100
Biochemical Research Methods
7173
Biochemistry & Molecular Biology
30370
Biodiversity Conservation
334
Biology
8585
Biophysics
8374
Biotechnology & Applied Microbiology
8609
Cardiac & Cardiovascular Systems
31601
Cardiovascular & Respiratory Systems
1423
Cell & Tissue Engineering
711
Cell Biology
11328
Chemistry, Analytical
4315
Chemistry, Applied
11085
Chemistry, Medicinal
8782
Chemistry, Multidisciplinary
18678
Clinical Immunology & Infectious Disease
482
Clinical Medicine
9019
Clinical Neurology
16921
Clinical Psychology & Psychiatry
1317
Critical Care Medicine
3275
Dentistry, Oral Surgery & Medicine
13735
Dermatology
7623
Developmental Biology
7048
Ecology
650
Education, Scientific Disciplines
2075
Emergency Medicine
4179
Endocrinology, Metabolism & Nutrition
24696
Engineering, Biomedical
3842
Entomology
457
Environmental Medicine & Public Health
4783
Evolutionary Biology
269
Gastroenterology & Hepatology
12494
General & Internal Medicine
7045
Genetics & Heredity
15239
Geriatrics & Gerontology
5305
Gerontology
372
Health Care Sciences & Services
16339
Health Policy & Services
656
Immunology
24976
Infectious Diseases
14183
Integrative & Complementary Medicine
2969
Medical Ethics
1218
Medical Informatics
2304
Medical Laboratory Technology
433
Medicine, General & Internal
44999
Medicine, Legal
541
Medicine, Research & Experimental
17991
Microbiology
23490
Mycology
0
Nanoscience & Nanotechnology
5460
Neuroimaging
1415
Neurology
4613
Neurosciences
40330
Nursing
9909
Nutrition & Dietetics
7965
Obstetrics & Gynecology
8439
Oncology
52996
Ophthalmology
9831
Optics
4320
Orthopedics
11946
Orthopedics, Rehabilitation & Sports Medicine
1832
Otolaryngology
1612
Otorhinolaryngology
5001
Parasitology
1132
Pathology
5212
Pediatrics
21953
Peripheral Vascular Disease
4957
Pharmacology & Pharmacy
35772
Pharmacology/Toxicology
12161
Physiology
8993
Polymer Science
547
Primary Health Care
893
Psychiatry
19399
Psychology
5353
Psychology, Applied
121
Psychology, Biological
374
Psychology, Clinical
805
Psychology, Developmental
248
Psychology, Educational
169
Psychology, Experimental
169
Psychology, Mathematical
0
Psychology, Multidisciplinary
1739
Psychology, Psychoanalysis
41
Psychology, Social
121
Public Health & Health Care Science
2282
Public, Environmental & Occupational Health
27665
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12645
Radiology, Nuclear Medicine & Medical Imaging
8241
Rehabilitation
3132
Remote Sensing
0
Reproductive Biology
2897
Reproductive Medicine
1208
Research/Laboratory Medicine & Medical Technology
4043
Respiratory System
7632
Rheumatology
6134
Social Sciences, Biomedical
1247
Substance Abuse
2775
Surgery
34521
Toxicology
4490
Transplantation
955
Tropical Medicine
314
Urology & Nephrology
13346
Veterinary Sciences
35
Virology
2505
Zoology
0
Channels
BLOOD CANCER JOURNAL
472
Hematology\Oncology
3
Medrxiv - Hematology
236
AMERICAN JOURNAL OF HEMATOLOGY
236
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
20
BRITISH JOURNAL OF HAEMATOLOGY
460
CIRCULATION RESEARCH
363
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
572
HAEMOPHILIA
143
JOURNAL OF CLINICAL APHERESIS
57
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
258
LANCET HAEMATOLOGY
29
THERAPEUTIC ADVANCES IN HEMATOLOGY
35
ACTA HAEMATOLOGICA
159
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
170
BLOOD COAGULATION & FIBRINOLYSIS
67
BLOOD PURIFICATION
188
CURRENT OPINION IN HEMATOLOGY
43
EUROPEAN JOURNAL OF HAEMATOLOGY
95
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
237
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
231
HAMOSTASEOLOGIE
207
ASIAN JOURNAL OF TRANSFUSION SCIENCE
20
EGYPTIAN JOURNAL OF HAEMATOLOGY
35
HEMASPHERE
404
HEMATOLOGY REPORTS
17
IRAQI JOURNAL OF HEMATOLOGY
88
CURRENT HEMATOLOGIC MALIGNANCY REPORTS
120
INTERNATIONAL JOURNAL OF HEMATOLOGY
592
JOURNAL OF HEMATOPATHOLOGY
167
SCI Abstract
search
ALL
RECOMMENDED
+
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
Response and progression criteria are necessary for any malignancy to standa...
Blood Cancer Journal
comment
0
thumb_up
0
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
Accumulating evidence suggests that blinatumomab (a CD3-CD19 bispecific T-ce...
Blood Cancer Journal
comment
0
thumb_up
0
Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases
Anemia after allogeneic hematopoietic stem cell transplantation (allo-HSCT) ...
Blood Cancer Journal
comment
0
thumb_up
0
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry
Despite the considerable effort to characterize the genomic landscape of chronic lymphocytic leukemia (CLL), published dat...
Blood Cancer Journal
comment
0
thumb_up
0
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development
Patients with relapsed/refractory multiple myeloma (RRMM) have a poor prognosis and a need remains for novel effective the...
Blood Cancer Journal
comment
0
thumb_up
0
Defining ‘Intention’ in intention-to-treat survival outcomes for chimeric antigen receptor T-cell therapy
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4....
Blood Cancer Journal
comment
0
thumb_up
0
Comparing the efficacy and safety of venetoclax combined with hypomethylating agents versus intensive chemotherapy as induction therapy in newly diagnosed core binding factor acute myeloid leukemia patients
CBF-AMLs, which account for approximately 12–15% of all AML cases, involve c...
Blood Cancer Journal
comment
0
thumb_up
0
Correction: A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4....
Blood Cancer Journal
comment
0
thumb_up
0
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial
Given the early use of triplet and quadruplet regimens, most patients with multiple myeloma (MM) will be exposed and/or re...
Blood Cancer Journal
comment
0
thumb_up
1
Association of ADAM family members with proliferation signaling and disease progression in multiple myeloma
Multiple myeloma (MM) is a hematological malignancy whose curability is greatly challenged by recurrent patient relapses a...
Blood Cancer Journal
comment
0
thumb_up
0
Bispecific antibodies in the treatment of multiple myeloma
The treatment paradigm in myeloma is constantly changing. Upfront use of monoclonal antibodies like daratumumab along with...
Blood Cancer Journal
comment
0
thumb_up
0
Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma
First-line treatment for advanced-stage diffuse large B-cell lymphoma (DLBCL) typically involves 6x R-CHOP21 or 6x R-CHOP2...
Blood Cancer Journal
comment
0
thumb_up
0
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients
Lenalidomide, bortezomib, and dexamethasone (RVd) have previously been established as standard-of-care induction therapy f...
Blood Cancer Journal
comment
0
thumb_up
0
Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S, et al. Prognostic implication of FLT3 and N-RAS gene mutations ...
Blood Cancer Journal
comment
0
thumb_up
0
Multiomic analysis identifies a high-risk subgroup that predicts poor prognosis in t(8;21) acute myeloid leukemia
Begna KH, Xu X, Gangat N, Alkhateeb H, Patnaik MM, Al-Kali A, et al. Core-binding factor acute myeloid leukemia: long-term...
Blood Cancer Journal
comment
0
thumb_up
0
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy
Therapy-related acute myeloid leukemia (t-AML) often exhibits adverse (genetic) features. There is ongoing discussion on t...
Blood Cancer Journal
comment
0
thumb_up
0
Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison
Competing interests MS reports receiving funding from BeiGene paid to Fred...
Blood Cancer Journal
comment
0
thumb_up
0
A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping
Multiple myeloma (MM) is a plasma cell neoplasm (PCN) [1]. Sensitive and accurate identification of g...
Blood Cancer Journal
comment
0
thumb_up
0
Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis
TP53 mutations (TP53Mut) define the most rapidly fatal AML subtype [1, 2] (Supplementary Fig. S1A). We used AML datasets (...
Blood Cancer Journal
comment
0
thumb_up
0
The landscape of NUP98 rearrangements clinical characteristics and treatment response from 1491 acute leukemia patients
Nucleoporin 98 (NUP98, chromosome 11p15) fusion oncoproteins also called NUP98 rearrangements (NUP98r...
Blood Cancer Journal
comment
0
thumb_up
0
T cells with high BCL-2 expression induced by venetoclax impact anti-leukemic immunity “graft-versus-leukemia effects”
BCL-2, a crucial regulator of the mitochondrial apoptotic pathway, maintains myeloblast survival by s...
Blood Cancer Journal
comment
0
thumb_up
0
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
CAR-T cell therapy has led to a significant advance in the treatment of refractory/relapsed diffuse l...
Blood Cancer Journal
comment
0
thumb_up
0
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
Autologous stem cell transplantation (autoHCT) is considered standard of care for newly diagnosed multiple myeloma (MM). A...
Blood Cancer Journal
comment
0
thumb_up
0
Timing and co-occurrence of symptoms prior to a diagnosis of light chain (AL) amyloidosis
It is well-established that most patients with systemic light chain (AL) amyloidosis have multi-organ involvement and are ...
Blood Cancer Journal
comment
0
thumb_up
0
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis
Survey of interpretation practices of unbalanced MYC break-apart resultsFifty-four responses were obtained to the survey q...
Blood Cancer Journal
comment
0
thumb_up
0
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
Competing interests EM and VG have no conflicts of interest to disclose. S...
Blood Cancer Journal
comment
0
thumb_up
0
Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M
Myelodysplastic neoplasms (MDS) are hematopoietic stem cell (HSC) disorders arising in the bone marro...
Blood Cancer Journal
comment
0
thumb_up
0
Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?
Nucleophosmin 1 (NPM1) is one of the most frequently mutated genes (~30% of cases) in acute myeloid l...
Blood Cancer Journal
comment
0
thumb_up
0
Sociodemographic associations with uptake of novel therapies for acute myeloid leukemia
Inequitable uptake of novel therapies (NT) in non-cancer settings are known for patients with lower socioeconomic status (...
Blood Cancer Journal
comment
0
thumb_up
0
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands
Diffuse large B-cell lymphoma (DLBCL) is a common and aggressive form of non-Hodgkin lymphoma primari...
Blood Cancer Journal
comment
0
thumb_up
0
Load More
Modal title
×
Modal title
×
Share
Login
Global News and Health Forum
Join Now!
Member Login
Remember me
Forgot password?
Or using
Linkedin